Abstract Title:

Melatonin attenuates hepatic ischemia through mitogen-activated protein kinase signaling.

Abstract Source:

J Surg Res. 2015 May 29. Epub 2015 May 29. PMID: 26101163

Abstract Author(s):

Sang-Ah Gim, Phil-Ok Koh

Article Affiliation:

Sang-Ah Gim


BACKGROUND: Melatonin exerts a protective effect during hepatic ischemia-reperfusion (I/R) injury through modulation of the apoptotic cell death program. Mitogen-activated protein kinases mediate various intracellular processes such as cell differentiation, survival, and death. This study investigated whether melatonin exerts a protective effect through the activation of Raf-MEK-ERK and its downstream targets, including 90 ribosomal S6 kinase (p90RSK) and Bad, during hepatic I/R damage.

METHODS: Hepatic ischemia was induced in mice by occlusion of the hepatic artery, portal vein, and bile duct. Adult mice were subjected to 1 h of hepatic ischemia and 3 h of reperfusion. Vehicle or melatonin (10 mg/kg, intraperitoneal) was injected 15 min before ischemia and just before reperfusion. Serum aspartate aminotransferase and alanine aminotransferase levels were measured, and terminal deoxynucleotidyl transferase dUTP nick-end labeling histochemistry was performed. Moreover, Western blot and immunoprecipitation analyses were performed.

RESULTS: Melatonin treatment attenuated hepatic I/R-induced increases in alanine aminotransferase and aspartate aminotransferase levels and also ameliorated hepatic injury-induced pathologic lesions and increases of positive terminal deoxynucleotidyl transferase dUTP nick-end labeling staining in hepatic tissues. Hepatic I/R injury induced decreases in the phosphorylation of Raf-1, MEK1/2, and extracellular-regulated kinase (ERK)1/2, whereas melatonin attenuated decreases in these phosphorylation levels. Moreover, melatonin prevented the injury-induced decreases in phosphorylation of downstream targets, p90RSK and Bad. Immunoprecipitation analysis showed that the interaction between phospho-Bad and 14-3-3 was decreased in vehicle-treated animals, while melatonin prevented this decrease. Melatonin also attenuated the injury-induced increase in cleaved caspase-3. In cultured hepatocytes, melatonin treatment prevented the hydrogen peroxide-induced cell death and decrease in phosphorylation of ERK1/2. Moreover, blocking MEK by PD98059 attenuated the effect of melatonin.

CONCLUSIONS: These data suggest that melatonin protects hepatic cells against hepatic I/R damage through the activation of the Raf-MEK-ERK cascade and phosphorylation of its downstream targets.

Study Type : Animal Study

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2021 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.